Search Results

Nusano Selected for U.S. Nuclear Energy Launch Platform Program to Advance Advanced Nuclear Fuel Production Line

Nusano, Inc., a physics company based in West Valley City, Utah, that has made breakthroughs in radioisotope and nuclear fuel production, has been selected by the U.S. Nuclear Reactor Innovation Center (NRIC) and the U.S. Department of Energy (DOE) to participate in the development of a HALEU (high-assay low-enriched uranium) nuclear fuel production line as part of the Nuclear Energy Launch Platform program. The program is a federal government initiative aimed at accelerating innovative nuclear technologies from concept to commercial deployment. Through this program, Nusano will receive authorization process support from the U.S. Department of Energy, expertise from national laboratories, infrastructure, technical resources, and project support, thereby accelerating the development of advanced nuclear technologies...

2026-09-15

Siemens Healthineers Completes PET Detector Manufacturing Expansion Project in Tennessee, USA

Siemens Healthineers recently completed the expansion and renovation project of its PET detector center in Rockford, Tennessee, USA, with a total investment of $43.6 million. The project aims to enhance PET detector manufacturing capacity to meet the growing demand for PET/CT scanning equipment. The project added 40,000 square feet of building area to the existing 97,000-square-foot campus and renovated 7,500 square feet of existing space. The Rockford facility is Siemens Healthineers' only manufacturing site globally for producing PET detectors used in its PET/CT systems. The expansion includes 36,000 square feet of dedicated manufacturing space and a 4,000-square-foot expansion of R&D facilities; meanwhile, the company also renovated...

2026-09-10

Verdera Energy to Sell 100% Interest in Treeline Uranium Project in New Mexico, USA

Verdera Energy Corp. recently announced that it has entered into a mineral property purchase and sale agreement with Americas Uranium Corp. to sell 100% of its interest in the Treeline uranium project located in New Mexico, USA, with the transaction remaining subject to related royalty arrangements. Under the agreement, Americas Uranium will acquire all interests in the Treeline mineral properties and related titles. The consideration includes US$100,000 in cash payable at closing, and Americas Uranium common shares totaling C$2 million payable in installments over 36 months following closing, with 90% of the share consideration to be paid in stages within that period. In addition, Verdera will retain a 1.5% net proceeds royalty on uranium from the project and a 1.5% net smelter returns royalty on other minerals produced from the project. The royalty can be reduced to 1.0% upon payment of C$400,000 to Verdera.

2026-09-03

Busan, South Korea Secures 2027 Budget Support; Export-Oriented Research Reactor and Other Projects Included in Government Proposal

Busan Metropolitan City recently announced that multiple national projects aligned with its core development goals have been included in the South Korean government's 2027 budget proposal, including the Gadeok Island New Airport, a new export-oriented research reactor, a heavy ion accelerator, as well as industrial projects such as port artificial intelligence, naval vessel maintenance, repair and overhaul, and power semiconductors. Under the budget arrangement, the Gadeok Island New Airport construction project has secured 431.1 billion KRW in support. To enhance maritime and logistics competitiveness, the budget proposal also includes 7.35 billion KRW for a demonstration project on autonomous port cargo handling equipment, 36.4 billion KRW to support shipbuilding and shipping cooperation, 5 billion KRW to strengthen the global competitiveness of small and medium-sized shipbuilders in naval vessel maintenance, repair and overhaul, and an additional 24.9 billion KRW allocated for the development of a fishery products industrial cluster.

2026-09-02

Blueprint for Proton Therapy Center in Southeastern Busan, South Korea Unveiled to Address Regional Gap in Cancer Treatment Resources

The blueprint for the proton therapy center at the Southeastern Regional Nuclear Medicine Center in Gijang-gun, Busan, South Korea, was recently unveiled. The project is expected to help bridge the gap in cancer treatment resources between the Seoul metropolitan area and non-capital regions, and to promote the application of proton accelerators in high-tech industries. According to information from Gijang-gun, Busan, and the Southeastern Regional Institute of Radiation Medicine on August 29, the Busan Institute of Science and Technology Higher Education recently published a service report titled "Establishment of Promotion Strategy and Implementation Plan for the Southeastern Proton Therapy Center," which includes the construction blueprint and feasibility analysis of the center. The Southeastern Regional Institute of Radiation Medicine is advancing related preparatory work in response to the research and development review by the Ministry of Science and ICT in the second half of this year...

2026-08-30

Bristol Myers Squibb to Invest $173 Million in New Radiopharmaceutical Plant in Indiana, USA

Bristol Myers Squibb's RayzeBio will build a new radiopharmaceutical production facility in Whitestown, Indiana, USA, with an investment of $173 million. The project will be located at the Anson Industrial Park in Boone County, with construction planned to begin this year, complementing RayzeBio's existing operational radiopharmaceutical plant in Indianapolis. According to information released by the state of Indiana, the new facility will cover approximately 225,000 square feet. Bristol Myers Squibb expects the two production sites to add 100 new positions by the end of 2029, with annual salaries for new positions expected to exceed $130,000. Bristol Myers Squibb acquired San Diego-based RayzeBio in 2023 for $4.1 billion...

2026-08-28

Busan, South Korea Reports No Abnormal Radiation Detected in Seawater and Seafood Three Years After Fukushima Discharge

Busan Metropolitan City stated on August 24 that since the discharge of contaminated water from the Fukushima nuclear power plant began in 2023, the city has continuously conducted radiation monitoring and analysis of coastal seawater and seafood. The results show that the safety conditions of Busan's waters and seafood remain stable with no abnormal changes detected. According to Busan Metropolitan City, seawater radioactivity testing is currently conducted at 26 coastal points. Among them, samples from 14 coastal locations including Haeundae, Gwangalli, Dadaepo, Songdo, and Songjeong are analyzed by the Busan Metropolitan City Institute of Health and Environment and local university research institutions. Test results show that the concentrations of relevant radionuclides are far below the World Health Organization drinking water standards, with cesium-134,...

2026-08-24

Urenco USA Breaks Ground on National Enrichment Facility Expansion, Plans to Add 2.1 Million SWU Capacity

On August 18, local time, Urenco USA held a groundbreaking ceremony in Eunice, New Mexico, United States, to launch the future expansion of its commercial uranium enrichment facility. U.S. Secretary of Energy Chris Wright, Urenco Group Chief Executive Officer Boris Schucht, and company management attended the ceremony. Urenco USA is the only commercial-scale uranium enrichment producer in the United States, operating the National Enrichment Facility (NEF). The company announced in June this year that it would increase the facility's capacity by nearly 50%. This expansion is part of a multi-billion-dollar investment, with plans to build a new...

2026-08-19

Terra Clean Energy Receives Exploration Permit for Marysvale Uranium Project in Utah, USA

Terra Clean Energy Corp. recently announced that it has received the relevant permit from the Utah Division of Oil, Gas and Mining under the Utah Department of Natural Resources to carry out planned exploration work at its wholly-owned Marysvale Uranium Project. Under the approved work plan, the company will construct 5 drill pads to support subsequent diamond core drilling, and excavate 7 exploration trenches to expose and evaluate known uranium-bearing outcrops. Terra stated that this permit represents a significant milestone in advancing this historic uranium project. The trenching work will help the company's technical team map mineralized structures, collect samples, and validate existing geological interpretations. The results will...

2026-08-18

South Korea's Honam Region Visits Busan Gijang for SMR Experience, Seeking New Solutions for Stable Semiconductor Power Supply

South Korea's South Jeolla Province and Gwangju region are paying attention to Small Modular Reactors (SMR) as a potential alternative for semiconductor industry power supply. On August 7, members of the "South Jeolla-Gwangju SMR-AI Energy Forum" visited the Gijang-gun Jangan-eup Gilcheon-ri Village Hall in Busan to hold discussions with the local nuclear safety consultative body, village representatives, the Gori headquarters of Korea Hydro & Nuclear Power, and relevant Gijang-gun departments, focusing on understanding Gijang's autonomous pursuit process and resident communication experience in the siting of the innovative Small Modular Reactor (i-SMR). The direct background of this visit is the potential stable power supply challenge that the semiconductor industry in the Honam region may face in the future. Semiconductor manufacturing relies heavily on continuous, reliable large-scale...

2026-08-11

South Korea's Deepnoid Signs M4CXR Supply Contract with Pusan National University Hospital

On August 3, Deepnoid announced the signing of a supply contract for M4CXR with Pusan National University Hospital. M4CXR is a generative AI-based preliminary report generation solution for chest X-rays that generates preliminary reports during chest X-ray examinations to assist medical staff in image interpretation. This is the first supply agreement signed after M4CXR received approval from the Ministry of Food and Drug Safety of South Korea for market release as a digital medical device. According to the introduction, the system is expected to improve the efficiency of chest X-ray reading and provide clinical support for the early detection of lung diseases and suspected cancerous lesions. This collaboration is also part of the AI clinical system support project for regional responsible medical institutions under the Ministry of Health and Welfare of South Korea...

2026-08-03

Busan Gijang Southeast Radiation Medical Science Industrial Complex Simultaneously Advances Proton and Heavy Ion Therapy Centers

Within the Southeast Atomic Energy Medical Institute (Southeast Atomic Energy Medical Institute) in Gijang-gun, Busan, the proton therapy center and heavy ion therapy center projects are being advanced simultaneously, expected to form an integrated cancer treatment hub, alleviate medical concentration in the capital region, and attract patients from other regions and overseas. Busan's first proton accelerator project can also be used for industrial purposes, benefiting regional high-tech industries and investment attraction. According to Busan City and the Busan Institute of Science and Technology Advancement (BISTEP) on August 2, the Southeast Proton Therapy Center construction project will officially break ground in the second half of this year; BISTEP recently completed a commissioned study on the establishment strategy and implementation plan for the Southeast Proton Therapy Center (executed by the Southeast Atomic Energy Medical Institute) (Southeast...

2026-08-03

Moffitt Cancer Center Activates Proton Therapy Center in Florida, USA

Moffitt Cancer Center recently held a ribbon-cutting ceremony, announcing the official opening of the Richard M. Schultz Family Foundation Proton Center at the Moffitt Speros Outpatient Center. Located in the Speros Global R&D Park in Pasco County, Florida, it is recognized as the first proton therapy center in the Tampa Bay area. Moffitt Cancer Center stated that the activation of the proton therapy center will provide local patients with more precise radiotherapy options. Built in collaboration with IBA, a particle accelerator technology company, the center will use proton therapy to deliver targeted radiation to tumors, improving tumor targeting accuracy while minimizing impact on surrounding healthy tissues. According to reports, the...

2026-07-30